Cefepime/Nacubactam
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cefepime/Nacubactam, covering 2025-11-25 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales [Phase 3]